Skip to search formSkip to main contentSkip to account menu

cytarabine/daunorubicin protocol

Known as: cytarabine/daunorubicin (CAD), CAD, DA 
cancer treatment drug
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
BACKGROUND Burkitt's lymphoma is an aggressive B-cell lymphoma that occurs in children and adults and is largely curable with the… 
Highly Cited
2010
Highly Cited
2010
PURPOSE To optimize treatment for younger patients with acute myeloid leukemia and high-risk myelodysplastic syndrome by… 
Highly Cited
2008
Highly Cited
2008
Ring-opening reaction of low molecular weight polyethylenimine with an Mw of 800 Da (800 Da PEI) with methylthiirane produced… 
Review
2001
Review
2001
Background The laryngeal mask airway (LMA™; LMA North America, Inc., San Diego, CA) has a well-established role in the emergency… 
Highly Cited
1996
Highly Cited
1996
Liver allografts in some rat strains are often spontaneously accepted across a complete major histocompatibility barrier without… 
Highly Cited
1986
Highly Cited
1986
Abstract We assessed the safety and efficacy of Fluosol-DA as a red-cell substitute in acute anemia. Twenty-three surgical… 
Highly Cited
1982
Highly Cited
1982
After the experimental and phase one studies of our so-called "artificial blood," Fluosol-DA (20%), an emulsified mixture of…